A new cancer-detecting tool uses tiny circuits made of DNA to identify cancer cells by the molecular signatures on their surface.
Duke University researchers fashioned the simple circuits from interacting strands of synthetic DNA that are tens of thousands of times finer than a human hair.
Unlike the circuits in a computer, these circuits work by attaching to the outside of a cell and analyzing it for proteins found in greater numbers on some cell types than others. If a circuit finds its targets, it labels the cell with a tiny light-up tag.
Because the devices distinguish cell types with higher specificity than previous methods, the researchers hope their work might improve diagnosis, and give cancer therapies better aim.
A team led by Duke computer scientist John Reif and his former Ph.D. student Tianqi Song described their approach in a recent issue of the Journal of the American Chemical Society.
Similar techniques have been used previously to detect cancer, but they’re more prone to false alarms — misidentifications that occur when mixtures of cells sport one or more of the proteins a DNA circuit is designed to screen for, but no single cell type has them all.
For every cancer cell that is correctly detected using current methods, some fraction of healthy cells also get mislabeled as possibly cancerous when they’re not.
Each type of cancer cell has a characteristic set of cell membrane proteins on its cell surface. To cut down on cases of mistaken identity, the Duke team designed a DNA circuit that must latch onto that specific combination of proteins on the same cell to work.
As a result they’re much less likely to flag the wrong cells, Reif said.
The technology could be used as a screening tool to help rule out cancer, which could mean fewer unnecessary follow-ups, or to develop more targeted cancer treatments with fewer side effects.
Each basic element of their DNA circuit consists of two DNA strands. The first DNA strand folds over and partially pairs up with itself to form a hairpin shape. One end of each hairpin is bound to a second strand of DNA that acts as a lock and tether, folding in such a way to fit a specific cell surface protein like a puzzle piece. Together these two strands act to verify that that particular protein is present on the cell surface.
To look for cancer, the circuit components are mixed with a person’s cells in the lab. If any cells are studded with the right combination of proteins, the complete circuit will attach. Adding a strand of “initiator” DNA then causes one of the hairpins to open, which in turn triggers another in a chain reaction until the last hairpin in the circuit is opened and the cell lights up.
Test runs of the device in test tubes in Reif’s lab showed it can be used to detect leukemia cells and to distinguish them from other types of cancer within a matter of hours, just by the strength of their glow.
The devices can be easily reconfigured to detect different cell surface proteins by replacing the tether strands, the researchers say. In the future, Reif plans to expand the device to release a small molecule that alerts the body’s immune system to attack the cancer cell.
The technology isn’t ready for prime time yet. The researchers say their DNA circuits require testing in more realistic conditions to make sure they still flag the right cells.
But it’s a promising step toward ensuring that cancer screens and therapies zero in on the right culprits.
Learn more: I.D. VERIFICATION, NOW FOR CANCER
The Latest Google Headlines on:
The Latest Bing News on:
- Cultivation of Exoelectrogenic Bacteria in Conductive DNA Nanocomposite Hydrogels Yields a Programmable Biohybrid Materials Systemon March 21, 2020 at 6:39 pm
Institute for Biological Interfaces (IBG 1), Karlsruhe Institute of Technology (KIT), Hermann-von-Helmholtz-Platz 1, 76344 Eggenstein-Leopoldshafen, Germany Institute for Biological Interfaces (IBG 1) ...
- Circulating tumor DNA and liquid biopsy in oncologyon March 20, 2020 at 9:05 am
Evaluation of circulating tumor DNA in blood has emerged as a powerful technology for oncology research. Lillian Siu and colleagues review the potential applications of liquid biopsy, highlighting ...
- Applied DNA Secures Global Top-20 Pharmaceutical Manufacturer as Drug Development Customeron March 20, 2020 at 8:43 am
About Applied DNA Sciences, Inc. Applied DNA is a provider of molecular technologies that enable supply chain security, anti-counterfeiting and anti-theft technology, product genotyping, diagnostics ...
- DNA evidence on discarded cigarette leads Florida authorities to killer in decades-old cold caseon March 19, 2020 at 11:50 pm
But thanks to advancements in technology and DNA analysis, authorities’ most recent lead panned out. They were able link McKinley’s killer to Wells’ family using genetic genealogy — a technique that ...
- Spartan Bioscience investigating ways to use their rapid, on-site DNA testing technology to help with the COVID-19 outbreakon March 19, 2020 at 10:49 pm
sample-to-result DNA testing platform that is designed for in-field diagnostic testing. Spartan's technology has regulatory approvals worldwide, including FDA 510(k), European CE IVD Mark, and Health ...
- Research update : In 2020, DNA Sequencing Market :Government Initiatives to Instill More Funds Can Transformon March 19, 2020 at 9:48 pm
Market Research Future (MRFR) has determined the time frame as the forecast period in their report on the same. DNA sequencing is a technology that is rapidly getting introduced in various ...
- XSEDE Supercomputers Complete Simulations Pertinent to coronavirus, DNA Replicationon March 19, 2020 at 7:49 am
Said Roston: “DNA replication is what life is about. We’re getting at the heart of how that happens, the really fundamental process to life as we know it on Earth. This is so important, we should ...
- How a Jane Doe child case uncovered a serial killer, identified victims and changed the use of DNA forensicson March 19, 2020 at 3:27 am
The Rasmussen case helped change forensic investigations forever with the introduction of the use of genetic genealogy.
- Using DNA: How Finding Variation Among Patients May Help Mitigate the Spread of Coronaviruson March 18, 2020 at 11:16 pm
We don’t even know if someone’s chances of severe symptoms from the coronavirus are affected by their genes. We could, however, answer these questions relatively cheaply and rapidly by using ...
- Recombinant DNA Technology Market Size, Industry Share and Growth Rate 2020-2026on March 17, 2020 at 1:23 am
The GlobalRecombinant DNA TechnologyMarket will grow considerably in the coming years due to exceptional scientific advancements in gene therapy. According to a report by Fortune Business Insights, ...
The Latest Google Headlines on:
Targeted cancer treatments
The Latest Bing News on:
Targeted cancer treatments
- Before Starting Targeted Therapy for Prostate Cancer, Determine Cardiovascular Riskon March 21, 2020 at 7:19 am
associate director of population science at the Sidney Kimmel Cancer Center—Jefferson Health, wrote in an email interview with Targeted Therapies in Oncology. “It is common that patients not eligible ...
- Case Report Details Continued Cancer Treatment During COVID-19 Infectionon March 20, 2020 at 8:24 am
Researchers recently published information about a patient with lung cancer who was also infected with SARS-CoV-2 who continued targeted therapy, despite the general practice of withdrawing cancer ...
- Researchers produce potential true theranostic agent for canceron March 20, 2020 at 5:04 am
"Scandium-47 is a beta-emitting radioisotope useful for targeted cancer therapy. However, unlike lutetium-177, scandium has the potential to be a true theranostic agent. The decay emissions of ...
- Comprehensive review of targeted therapy for colorectal canceron March 19, 2020 at 4:06 pm
Colorectal cancer (CRC) is among the most lethal and prevalent malignancies in the world and was responsible for nearly 881,000 cancer-related deaths in 2018. Surgery and chemotherapy have long been ...
- Ask the Expert: 8 Things to Know About Ovarian Cancer Treatments After Chemoon March 19, 2020 at 12:16 pm
Your doctor may recommend targeted therapies such as vascular endothelial growth factor (VEGF ... It also depends on the treatment you received and the way you responded to that treatment. Without ...
- Statins may protect against the heart harms of breast cancer therapieson March 19, 2020 at 7:46 am
Chemotherapies with anthracycline, as well as the targeted cancer medicine trastuzumab, are commonly used to treat breast cancer. Separate research estimates that nearly 1 out of 4 women with early ...
- Biomarker Test Industry Analysis 2020: Targeted Therapies to Pave Open Way for Growth for the Global Biomarker Test Marketon March 19, 2020 at 12:59 am
and rising prevalence of targeted therapies are factors expected to drive to market growth. Technological breakthroughs in diagnostic methods and emergence of personalized medicine can open up new ...
- Targeted nanoparticles swell-up to kill cancer cellson March 18, 2020 at 7:30 am
Grzybowski says the idea is still a long way from being turned into an anti-cancer treatment, but its mode of action is what excites him. Most anti-cancer drugs rely on apoptosis, or ‘cellular suicide ...
- African-American men less likely to use more targeted biopsy option for prostate canceron March 17, 2020 at 9:46 am
Researchers at the University of Cincinnati have found in a retrospective study that African-American men are less likely to use a more targeted biopsy option for prostate cancer ... this can lead to ...
- Global Markets for Drug Delivery in Cancer, Forecast to 2028 - Includes Coverage on Antisense, RNAi and Gene Therapy for Canceron March 12, 2020 at 5:51 pm
The "Drug Delivery in Cancer - Technologies, Markets & Companies" report from Jain PharmaBiotech has been added to ResearchAndMarkets.com's offering.